Submission Details
| 510(k) Number | K251200 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 18, 2025 |
| Decision Date | February 02, 2026 |
| Days to Decision | 290 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K251200 is an FDA 510(k) clearance for the Vital Signs, a Software For Optical Camera-based Measurement Of Pulse Rate, Heart Rate, Breathing Rate, And/or Respiratory Rate (Class II — Special Controls, product code QME), submitted by Oxehealth Limited (Abingdon, GB). The FDA issued a Cleared decision on February 2, 2026, 290 days after receiving the submission on April 18, 2025. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.2785.
| 510(k) Number | K251200 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 18, 2025 |
| Decision Date | February 02, 2026 |
| Days to Decision | 290 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | QME — Software For Optical Camera-based Measurement Of Pulse Rate, Heart Rate, Breathing Rate, And/or Respiratory Rate |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.2785 |
| Definition | The Device Uses Software Algorithms To Analyze Video Signal And Estimate Pulse Rate, Heart Rate, Respiratory Rate And/or Breathing Rates. This Device Is Not Intended To Independently Direct Therapy. |